Michigan Institute For Neurological Disorders MIND

Farmington Hills, Michigan

Dedicated MS Practice
8 Active TrialsInfusion CenterMedium Practice
8 MS centers statewide · Ranked #3 in Michigan for clinical trials
What kind of place is this?
Comprehensive Care TeamInfusion On-Site

You're stepping into a dedicated MS practice built around specialized neurologic care and long-term support. You'll likely appreciate the on-site infusion therapy, advanced testing, and a team that includes fellowship-trained MS specialists.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access3/5
Support Services3/5
Clinical Trials & Research3/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care2/5

About Michigan Institute For Neurological Disorders MIND

MIND combines a dedicated MS center with on-site infusion therapy and advanced neurologic testing, so many parts of care can happen in one place. The team includes fellowship-trained MS specialists and an MS center director focused on long-term care.

Michigan Institute For Neurological Disorders MIND provides long-term care for people living with multiple sclerosis, from diagnosis support to ongoing symptom and relapse management. The team offers infusion therapy, advanced MRI imaging, EEG and EMG testing, and coordinated neurological care in one setting. Patients also see fellowship-trained MS specialists, including Martin Belkin, William Boudouris, Taylor Hess, and Jonathan Doty. With two locations and a multidisciplinary team, the practice serves patients who want specialized MS care close to home.

Michigan Institute For Neurological Disorders MIND is a dedicated MS center in Farmington Hills with a team that includes MS specialists and fellowship-trained neurologists. You can get coordinated care for multiple sclerosis along with help for related neurologic conditions like migraine, epilepsy, stroke, and neuropathies. The center offers on-site infusion therapy, MRI imaging, EEG and EMG testing, and personalized treatment planning. It has been featured in Downriver Publications and Healio.

Featured Care Team Members

Martin Belkin
MS Center Director
Multiple sclerosis
William Boudouris
MS specialist
Multiple sclerosis
Taylor Hess
Neurologist and fellowship-trained MS specialist
Multiple sclerosis
Jonathan Doty, DO
Neurologist and fellowship-trained MS specialist
Multiple sclerosis

Specialized Programs

Multiple Sclerosis Center
Fellowship-trained MS specialist care
Long-term MS care

Services & Treatments

What They Treat
Multiple sclerosisStrokeVascular neurologic disordersEpilepsyMigraineNeurocognitive disordersNeuropathies
How They Treat It
Comprehensive neurological evaluationsInfusion therapyAdvanced MRI imagingEEG testingEMG testingIn-office proceduresRelapse managementDisease-modifying therapy coordinationSymptom managementPersonalized treatment planningCoordinated neurological careInfusion therapyAggressive disease-modifying treatmentSymptom managementBTK inhibitors
Diagnostics
Advanced MRI imagingEEG testingEMG testingAdvanced diagnosticsBiomarkers

Research & Clinical Trials

This center is currently involved in 8 clinical trials — ranked #3 in Michigan for active trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals
RECRUITINGPHASE3
Remibrutinib (blinded)PlaceboRemibrutinib (Open label)
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
ACTIVE NOT RECRUITINGPHASE3
TolebrutinibPlaceboTeriflunomide
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Amgen
RECRUITINGPHASE3
Ocrelizumab (US)Ocrelizumab (EU)ABP 692
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
RECRUITINGPHASE3
Remibrutinib oral treatmentOcrelizumab

Insurance & Access

Contact
28595 Orchard Lake Rd Suite 200, Farmington Hills, MI 48334
Insurance & Support

FAQs from Michigan Institute For Neurological Disorders MIND

Your care may involve Martin Belkin, the MS Center Director, along with MS specialist William Boudouris and fellowship-trained MS specialists Taylor Hess and Jonathan Doty. The center also has a multidisciplinary team that includes neurologists, nurse practitioners, and physician assistants.

Yes. MIND has on-site infusion therapy, which can make treatment more convenient for patients who need regular infusions as part of their MS plan.

The center offers advanced MRI imaging, EEG testing, and EMG testing. It also lists advanced diagnostics and biomarkers as part of its care tools.

MIND offers personalized treatment planning, relapse management, symptom management, and disease-modifying therapy coordination. The practice also mentions aggressive disease-modifying treatment and BTK inhibitors among treatment options.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website Book